Staccato Loxapine Multidose PK

Completed · Phase 1 · Has a placebo group

Conditions studied: Volunteers on Chronic, Stable Antipsychotic Regimens

In brief

The objectives of this trial are to assess the safety, tolerability, and pharmacokinetics of multiple inhaled doses of Staccato Loxapine.

Key facts

Study ID

NCT00555412

Run by

Alexza Pharmaceuticals, Inc.

People needed

40

Starts

2007-10-01

Expected to finish

2007-12-01

Last updated by the study team

2017-03-15

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Atlanta Center for Medical Research — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.